Study Reanalysis Using a Mechanism-Based Pharmacokinetic/Pharmacodynamic Model of Pramlintide in Subjects with Type 1 Diabetes

Jing Fang; Cornelia B. Landersdorfer; Brenda Cirincione; William J. Jusko; SL Aronoff; MS Fineman; J Gromada; A Young; F Evers; B Konarkowska; J Green; J McQueen; SV Edelman; BJ Hoogwerf; HP Chase; S Edelman; WA Colburn; W Byon; SL Beal; A Young; PJ Collins; H Minami; MF Kong; HE Silber; PM Jauslin; C Dalla Man; S Dinneen; MO Karlsson; M Bergstrand; MF Kong; JJ Lima; SH Lee; K Gumbhir-Shah; W Brener; M Horowitz; BR Gedulin; E Schvarcz; B Ludvik; D Singh-Franco; CB Landersdorfer; TV Nowak; AA Young; GJ Ryan; JB Buse; M Fineman; S Porksen; CB Landersdorfer

10.1208/s12248-012-9409-7

Study Reanalysis Using a Mechanism-Based Pharmacokinetic/Pharmacodynamic Model of Pramlintide in Subjects with Type 1 Diabetes

Authors: Jing Fang
Cornelia B. Landersdorfer
Brenda Cirincione
William J. Jusko
SL Aronoff
MS Fineman
J Gromada
A Young
F Evers
B Konarkowska
J Green
J McQueen
SV Edelman
BJ Hoogwerf
HP Chase
S Edelman
WA Colburn
W Byon
SL Beal
A Young
PJ Collins
H Minami
MF Kong
HE Silber
PM Jauslin
C Dalla Man
S Dinneen
MO Karlsson
M Bergstrand
MF Kong
JJ Lima
SH Lee
K Gumbhir-Shah
W Brener
M Horowitz
BR Gedulin
E Schvarcz
B Ludvik
D Singh-Franco
CB Landersdorfer
TV Nowak
AA Young
GJ Ryan
JB Buse
M Fineman
S Porksen
CB Landersdorfer
Publication date
Publisher: 'American Association of Pharmaceutical Scientists (AAPS)'

Abstract

Abstract is not available.

Similar works

Full text

Crossref

Full text is not available

Last time updated on 12/3/2019

This paper was published in Crossref.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.